PLATINUM announced the FDA approval of their ANDA submission, though specific product details and market implications are unavailable. Without a defin...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
ZYDUS PHARMS has received FDA approval for an ANDA (ANDA206097), a move that strengthens its commercial portfolio and is expected to create a signific...
Bausch Health US LLC secured FDA approval for the subcutaneous formulation of Brodalumab under the brand SILIQ, a move expected to significantly diver...
# FDA Approves Chattem's XYZAL ALLERGY 24HR for Over-the-Counter Use The FDA has approved Chattem, Inc.'s levocetirizine dihydrochloride formulation ...
# FDA Approves Chattem's Children's Xyzal Allergy Formulation Chattem, Inc. received FDA approval for Children's Xyzal Allergy (levocetirizine dihydr...
Zydus Pharmaceuticals USA Inc. received FDA approval for oral Methotrexate under ANDA207812, marking a potential new generic entry into a crowded mark...
# FDA Approves Saptalis Pharmaceuticals' Generic Desoximetasone Topical Treatment Saptalis Pharmaceuticals, LLC received FDA approval for its generic...
# FDA Approves Biogen's SPINRAZA for Spinal Muscular Atrophy, Opening Rare Disease Market Opportunity Biogen Inc. received FDA approval for SPINRAZA ...
UNICHEM PHARMACEUTICALS (USA), INC. has secured FDA approval for its preferred ANDA 207427 to manufacture generic metformin hydrochloride tablets, a m...
Boehringer Ingelheim today announced the FDA approval of SYNJARDY XR Empagliflozin/Metformin Hydrochloride, an extended-release oral tablet designed t...
Macleods Pharmaceuticals has received final approval from the US FDA for its generic Metformin Hydrochloride tablet salts, a product identified by AND...
Lupin Pharmaceuticals announced on December 1, 2016, the FDA approval of hydrocodone bitartrate and acetaminophen tablets, an ANDA filing, expanding t...
Aurobindo Pharma Limited announced approval of its Abbreviated New Drug Application for the generic version of Clozapine (ANDA #206433), introducing a...
# FDA Approves Sanofi's SOLIQUA 100/33, a Fixed-Dose Combination Insulin and GLP-1 Receptor Agonist Sanofi-Aventis U.S. LLC received FDA approval for...
Lupin Pharmaceuticals has received FDA approval for the generic version of Hydrocodone Bitartrate and Acetaminophen, targeting a product market curren...
Puracap Laboratories LLC doing business as Blu Pharmaceuticals has secured FDA approval for the oral rosuvastatin calcium generic, targeting the high-...
Accord Healthcare Inc. announced the FDA approval of its rosuvastatin calcium tablets, generating preliminary industry interest as a potential market ...
Unichem Pharmaceuticals (USA), Inc. received the long-awaited FDA approval Monday for its ANDA 207428, providing generic access to oral Sotalol Hydroc...
FDA has granted approval for an Abbreviated New Drug Application (ANDA) from PHARMOBEDIENT, marking a pivotal step into the market for the associated ...
Amneal Pharmaceuticals received approval for generic itraconazole (ANDA 205080) on September 26, 2016, which expands access to this antifungal oral me...